Jalandhra Gagan K, Srethbhakdi Lauryn, Davies James, Nguyen Chi Cong, Phan Phuoc Thien, Och Zachary, Ashok Aditya, Lim Khoon S, Phan Hoang-Phuong, Do Thanh Nho, Lovell Nigel H, Rnjak-Kovacina Jelena
Graduate School of Biomedical Engineering, University of New South Wales, Sydney, NSW, 2052, Australia.
School of Mechanical and Manufacturing Engineering, University of New South Wales, Sydney, NSW, 2052, Australia.
Adv Mater. 2025 Jul;37(27):e2420114. doi: 10.1002/adma.202420114. Epub 2025 Apr 17.
Heart disease encompasses a range of conditions that affect the heart, including coronary artery disease, arrhythmias, congenital heart defects, heart valve disease, and conditions that affect the heart muscle. Intervention strategies can be categorized according to when they are administered and include: 1) Monitoring cardiac function using sensor technology to inform diagnosis and treatment, 2) Managing symptoms by restoring cardiac output, electrophysiology, and hemodynamics, and often serving as bridge-to-recovery or bridge-to-transplantation strategies, and 3) Repairing damaged tissue, including myocardium and heart valves, when management strategies are insufficient. Each intervention approach and technology require specific material properties to function optimally, relying on materials that support their action and interface with the body, with new technologies increasingly depending on advances in materials science and engineering. This review explores material properties and requirements driving innovation in advanced intervention strategies for heart disease and highlights key examples of recent progress in the field driven by advances in materials research.
心脏病包括一系列影响心脏的病症,包括冠状动脉疾病、心律失常、先天性心脏缺陷、心脏瓣膜疾病以及影响心肌的病症。干预策略可根据其实施时间进行分类,包括:1)使用传感器技术监测心脏功能以辅助诊断和治疗;2)通过恢复心输出量、电生理学和血流动力学来管理症状,并且通常作为恢复或移植过渡策略;3)当管理策略不足时,修复受损组织,包括心肌和心脏瓣膜。每种干预方法和技术都需要特定的材料特性才能最佳发挥作用,这依赖于支持其作用并与身体相互作用的材料,新技术越来越依赖于材料科学与工程学的进展。本综述探讨了推动心脏病先进干预策略创新的材料特性和要求,并重点介绍了材料研究进展推动该领域近期进展的关键实例。
Adv Mater. 2025-7
2025-1
Cochrane Database Syst Rev. 2016-4-29
Arch Ital Urol Androl. 2025-6-30
Psychopharmacol Bull. 2024-7-8
ACS Sens. 2024-9-27
Biofabrication. 2024-7-25
Nat Commun. 2024-5-16
Adv Healthc Mater. 2024-9
Circulation. 2024-4-16
Adv Sci (Weinh). 2024-6